SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-216997
Filing Date
2023-08-21
Accepted
2023-08-21 16:33:57
Documents
1
Group Members
PAUL FRANKENIUS

Document Format Files

Seq Description Document Type Size
1 SC 13D d359872dsc13d.htm SC 13D 61949
  Complete submission text file 0001193125-23-216997.txt   63445
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Subject) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91951 | Film No.: 231189607
SIC: 8071 Services-Medical Laboratories

Mailing Address BOX 984 BORAS V7 SE-501 10
Business Address BOX 984 BORAS V7 SE-501 10 46 (0) 705-27 13 50
Frankenius Equity AB (Filed by) CIK: 0001988262 (see all company filings)

IRS No.: 000000000
Type: SC 13D